In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
BridgeBio Pharma Inc (NASDAQ: BBIO) closed the day trading at $22.54 up 0.85% from the previous closing price of $22.35. In other words, the price has increased by $0.85 from its previous closing price. On the day, 2.15 million shares were traded. BBIO stock price reached its highest trading level at $22.94 during the session, while it also had its lowest trading level at $21.72.
Ratios:
For a better understanding of BBIO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.19 and its Current Ratio is at 3.19.
On September 04, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $46.Piper Sandler initiated its Overweight rating on September 04, 2024, with a $46 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 19 ’24 when BRIAN STEPHENSON bought 4,156 shares for $22.35 per share.
NEIL KUMAR bought 27,389 shares of BBIO for $612,144 on Nov 19 ’24. On Sep 13 ’24, another insider, KKR Genetic Disorder L.P., who serves as the 10% Owner of the company, sold 5,800,000 shares for $25.75 each. As a result, the insider received 149,350,000 and left with 25,260,971 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BBIO now has a Market Capitalization of 4259834880 and an Enterprise Value of 5734785024. For the stock, the TTM Price-to-Sale (P/S) ratio is 19.56. Its current Enterprise Value per Revenue stands at 26.335 whereas that against EBITDA is -11.247.
Stock Price History:
Over the past 52 weeks, BBIO has reached a high of $44.32, while it has fallen to a 52-week low of $21.62. The 50-Day Moving Average of the stock is -10.50%, while the 200-Day Moving Average is calculated to be -17.78%.
Shares Statistics:
Over the past 3-months, BBIO traded about 2.04M shares per day on average, while over the past 10 days, BBIO traded about 2030330 shares per day. A total of 175.08M shares are outstanding, with a floating share count of 147.53M. Insiders hold about 21.94% of the company’s shares, while institutions hold 76.37% stake in the company. Shares short for BBIO as of 1730332800 were 17199451 with a Short Ratio of 8.44, compared to 1727654400 on 18628832. Therefore, it implies a Short% of Shares Outstanding of 17199451 and a Short% of Float of 14.08.
